OBP-004
Bone Metastasis (and other metastases)
PreclinicalActive
Key Facts
Indication
Bone Metastasis (and other metastases)
Phase
Preclinical
Status
Active
Company
About OncoBone Therapeutics
OncoBone Therapeutics is a Paris-based, privately held virtual CRO providing specialized preclinical project management and consulting services focused on osteoimmuno-oncology and bone metastasis models. Founded by seasoned scientists with deep CRO experience, the company operates as a service provider rather than a traditional drug developer, though its research has identified a novel compound, OBP-004. Its business model is built on leveraging an extensive network of high-quality CRO partners to offer clients efficient, expert-led program management in a niche but critical area of oncology research.
View full company profile